Dr. Reddy’s introduces generic REQUIP XL tablets in US
The launch was followed by the approval of Dr. Reddy’s ANDA by the US Food & Drug Administration (USFDA). Ropinirole Hydrochloride XR is the bioequivalent generic version of
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.